Dear Editor-in-Chief
Testis Cancer is the greatest common cancer in the 15-39 yr old men and with white Caucasian race. This cancer consists 0.7% of all men's cancer in the world. In western cultures, the testis cancer is the cause of 1%-1.5% of the men's cancer and 5 percent of the urinary tract cancer (1).
In the past 50 years in the worldwide, the incidence rate of testis cancer has increased trend (2). As a result, the number of incident cases of testis cancer in the world in the year 2008 and 2012 was more than 52000 and 55000 cases, respectively (3). The largest increase in the incidence of testis cancer was observed in Caucasian white race, while the lowest rates were observed in non-white races (4). Therefore, in the year 2012, the highest incidence of testis cancer has occurred in the west (5, 6) and northern Europe (5) while the lowest incidence has occurred in Asia and Africa (1) . In this year, the highest and lowest Age-Standardised Incidence Rates (rate per 100000 population at risk) of testis cancer in European countries was observed in Norway (12.2) and Russian Federation (1.7), respectively. Among European countries, there is a 7 times difference in the incidence rate of testis cancer In European countries between 2012 to 2035, based on GLOBOCAN Project (8) estimates incidence of testis cancer in people less than 65 yr will have declining trend, but in people, 65 yr and older will have rising trend. Probably increasing the proportion of elderly between 2012 to 2035 years is the cause of increasing trend in the incidence of testis cancer in the European countries. However, health policy makers must have planned for regular screening programs with the aim of diagnosis and treatment of testis cancer in the early stages of disease progression. Therefore, with early diagnosis and treatment of patients, in addition to improving the quality of life of patients, we can decline the number of patients that death due to testis cancer.
